Adapting Clinical Trial Best Practices to a Complex Global CDx Landscape

Get in Touch

Our Locations

Adapting Clinical Trial Best Practices to a Complex Global CDx Landscape

World CDx Europe 2019

This presentation reviews the central laboratory’s role for executing companion diagnostics globally, the requirements for effective collaboration between pharmaceutical and IVD companies regarding biomarkers. It focuses on key attributes required for complex oncology trials. Q²Solutions presented this lecture during the World CB and CDx Europe 2019 conference.

Download this presentation to learn more.

Related Services & Solutions

Related Thought Leaders Insights

Scientific Poster

Robust performance of single-cell multiomic analysis (CITE-Seq) demonstrated across multiple locations, replicates, and donors on challenging cryopreserved PBMC and BMMC samples

Q² Solutions is the first and only service provider to achieve the exclusive certified service partnership for CITE-Seq scRNA-Seq with BioLegend. Describes CITE-Seq performance expectations for...

Brochure

Challenging Bioanalytical Work

If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...

Factsheet

CNS Biomarkers

Rules-Based Medicine, a Q² Solutions company, offers ultrasensitive immunoassays – including beta-amyloids, GFAP, NF-L, and pTaus – for the development of diagnostics and therapeutics for Alzheimer’s...